Genome editing in plants – a technology with transformative potential
Editovanie genómu rastlín – technológia s transformatívnym potenciálom
Program: COST
Zodpovedný riešiteľ: Ing. Jopčík Martin PhD.
Annotation: A great challenge of this century is to provide adequate nutrition for an increasing global population while developing a more socially, economically and environmentally sustainable agriculture that counters climate change, biodiversity loss and degradation of arable land. Plant research and breeding are very important in meeting this challenge. Building on scientific progress, a number of genome editing techniques have been developed over the past two decades allowing an unprecedented level of precision in our control over genetic material and its corresponding traits.This COST Action will bring together expertise from a range of disciplines to evaluate plant genome editing techniques and their resulting products from various perspectives. The findings will serve to design a roadmap for directing and facilitating applications of genome editing in plant research and breeding, which in turn will help setting R&D priorities and stimulating further cross-national and cross-disciplinary collaborations.
Project web page:|Name:overview
Duration: 25.4.2019 – 24.4.2023


MASnPNO – Využitie myrozinázy na aktiváciu sulforafanu pre vývoj preparátu s preventívnymi účinkami nádorových ochorení
The application of myrosinase for sulforaphane activation in development of a novel product exhibiting cancer prevention effects
Program: APVV
Zodpovedný riešiteľ: doc. RNDr. Salaj Ján DrSc.
Annotation: Effects of sulphoraphane on cencer prevention was already proven. Sulforaphane is often presents in food at the non-effective level for fulfillment the prevention effects. In addition, the natural glucosinolate form of sulforaphane, glucorafanine, is much less effective, therefore its activation to sulforaphane is needed. This conversion is catalysed by enzyme, myrosinase (EC Aim of the current project is to design the new product based on sulforaphane-glucosinolate and stabilized myrosinase as combine product.
Duration: 1.7.2017 – 30.6.2021